PFE · 8-K · 20260804PR000094

Contract Manufacturing Operations

PFIZER INC · 2026-08-04 · Importance 46 · Surprise 56

Pfizer CentreOne revenue increased 7% worldwide to $373 million in the second quarter and 7% to $662 million for the first six months. International Pfizer CentreOne revenue grew 24% in the quarter and 14% for the first six months, reaching $306 million and $490 million, respectively. U.S. revenue declined 34% in the quarter and 10% for the first six months. Pfizer CentreOne includes contract manufacturing, active pharmaceutical ingredient sales and manufacturing and supply agreements with legacy Pfizer businesses and partnerships.

Key facts

• Pfizer CentreOne revenues for Six Months 2026: $662 million, up 7% (or 3% operational) versus 2025; U.S. $172 million down 10%; International $490 million up 14% source